Mark P. Jansen

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating MYBPC3 Founder Variant Carriers.

Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating MYBPC3 Founder Variant Carriers.

Journal: Circulation. Genomic and precision medicine

Published: December 17, 2024

Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy.

Clinical Features and Outcomes of Pediatric MYH7-Related Dilated Cardiomyopathy.

Journal: Journal of the American Heart Association

Published: November 04, 2024

Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy.

Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy.

Journal: Circulation. Genomic and precision medicine

Published: June 10, 2024

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants.

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants.

Journal: International journal of molecular sciences

Published: December 27, 2022

Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.

Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.

Journal: JACC. Heart failure

Published: December 06, 2022

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers.

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers.

Journal: Journal of cardiovascular translational research

Published: November 30, 2022

Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration.

Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration.

Journal: European heart journal

Published: June 11, 2022

Natural History of MYH7-Related Dilated Cardiomyopathy.

Natural History of MYH7-Related Dilated Cardiomyopathy.

Journal: Journal of the American College of Cardiology

Published: May 04, 2022

Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysis.

Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysis.

Journal: ESC heart failure

Published: March 13, 2022

Automatic Identification of Patients With Unexplained Left Ventricular Hypertrophy in Electronic Health Record Data to Improve Targeted Treatment and Family Screening.

Automatic Identification of Patients With Unexplained Left Ventricular Hypertrophy in Electronic Health Record Data to Improve Targeted Treatment and Family Screening.

Journal: Frontiers in cardiovascular medicine

Published: September 01, 2021

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.

Journal: Cells

Published: July 11, 2021

Mortality Risk Associated With Truncating Founder Mutations in Titin.

Mortality Risk Associated With Truncating Founder Mutations in Titin.

Journal: Circulation. Genomic and precision medicine

Published: May 22, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026